EMCURE.NS · Emcure Pharmaceuticals Limited
India · RS rating 73 · As of 2026-10-14
| Price | 1,866.20 INR |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 73 / 38 / 70 / 82 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 43 / 47 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +20.7% |
| Sales growth Q/Q | +4.5% |
| Distance from 52-week high | +7.1% |
| Market cap (USD) | $3.7B |